Add-on Acquisition • Life Science

Merck Acquires Sigma-Aldrich

On November 18, 2015, Merck acquired life science company Sigma-Aldrich for 17.0B USD

Acquisition Context

This is Merck’s 6th transaction in the Life Science sector.
This is Merck’s largest (disclosed) transaction.
This is Merck’s 5th transaction in the United States.
This is Merck’s 1st transaction in Missouri.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	November 18, 2015
Target	Sigma-Aldrich
Sector	Life Science
Buyer(s)	Merck
Deal Type	Add-on Acquisition
Deal Value	17.0B USD

Target Company

Sigma-Aldrich

St. Louis, Missouri, United States

Sigma-Aldrich Corp. is a life science and high technology company whose biochemical, organic chemical products, kits, and services are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical, diagnostics and high technology manufacturing. Sigma-Aldrich customers include more than 1.3 million scientists and technologists in life science companies, university, and government institutions, hospitals, and industry.

Explore More Deals

Browse All 215,156 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Merck

Darmstadt, Germany

Category	Company
Founded	1668
Sector	Diversified
Employees	64,011
Revenue	21.2B EUR (2024)

DESCRIPTION

Merck is a science and technology company in healthcare, life science, and performance materials. It develops technologies that improve and enhance life, from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. Merck was founded in 1668 and is based in Darmstadt, Germany.

Deal Context for Buyer	#
Overall	15 of 26
Sector: Life Science	6 of 12
Type: Add-on Acquisition	11 of 21
State: Missouri	1 of 1
Country: United States	5 of 12
Year: 2015	3 of 4
Size (of disclosed)	1 of 9

PREVIOUS DEAL

DATE	TARGET	DEAL TYPE	VALUE
2015-07-02	QLight Nanotech Jerusalem, Israel QLight Nanotech Ltd. developing materials and applications based on semiconductor nanocrystals. Qlight Nanotech’s leading technological team has significant expertise and innovation in nanoscience and nanotechnology, aimed at applications in general lighting, display panels, and more.	Buy	-

DATE

TARGET

DEAL TYPE

VALUE

2015-07-02

QLight Nanotech

Jerusalem, Israel

QLight Nanotech Ltd. developing materials and applications based on semiconductor nanocrystals. Qlight Nanotech’s leading technological team has significant expertise and innovation in nanoscience and nanotechnology, aimed at applications in general lighting, display panels, and more.

Buy

FOLLOWING DEAL

DATE	TARGET	DEAL TYPE	VALUE
2015-12-14	Ormet Circuits San Diego, California, United States Ormet Circuits, Incorporated (Ormet) is a privately held company, engaged in the design, manufacture, and sale of electrically conductive sintering pastes for use in the assembly of advanced electronic devices.	Buy	-

DATE

TARGET

DEAL TYPE

VALUE

2015-12-14

Ormet Circuits

San Diego, California, United States

Ormet Circuits, Incorporated (Ormet) is a privately held company, engaged in the design, manufacture, and sale of electrically conductive sintering pastes for use in the assembly of advanced electronic devices.

Buy

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - Missouri M&A - United States M&A - 2015 M&A